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ABSTRACT
Background: The most frequent hepatic circulatory abnormality in dogs is the portosystemic shunt, characterized by an 
atypical deviation of the hepatic blood flow, that causes the blood that should be drained by the liver through the portal 
vein to be diverted to another systemic vein, as a result of the presence of the anomalous vessel. This diversion leads to 
reduced hepatic blood flow and, consequently, organ dysfunction, along with the accumulation of many toxins in the 
circulation, for instance, ammonia and short-chain fatty acids. The main objective of this paper is to Report the clinical 
case of a canine female diagnosed with an extrahepatic portosystemic shunt and submitted to surgical treatment using an 
ameroid constrictor ring in the obstruction of the anomalous vessel.
Case: A canine Shih-Tzu, at the age of 1 year and 8 months, was brought to the Veterinary Hospital presenting a history of 
emesis and smaller body structure than other animals from the same litter. The animal had been diagnosed with portosystemic 
shunt at age 1 month, by means of complementary biochemistry, ultrasonography and computed tomography examinations. 
The latter identified the anomalous vessel, which originated from the left gastric vein and was inserted into the azygos vein 
in the portohepatic region. During the surgical intervention, after median pre-retro-umbilical celiotomy, a calibrous vessel 
was identified, coming out of the junction of two splenic veins and a gastric vein that penetrated the diaphragm and con-
nected to the azygos vein in the thorax before flowing into the vena cava. Given that, the diaphragm had to be sectioned, 
which lead to the loss of the negative intra-thoracic pressure, requiring muscle suturing to restore it. A small dissection 
was performed around the vessel for the ameroid constrictor placement. There was no complication during the procedure. 
Ten days after the surgery, the clinical evaluation and new blood tests showed that the patient was active, did not express 
pain and was fully recovered. Ten days after the first follow-up visit, the owners mentioned that the patient was reluctant to 
eat the prescribed diet, though she was clinically well and her blood test results were within normal ranges for the species. 
The animal did not have any episodes of apathy, anorexia or vomiting, gained weight (4.2 kg) and the clinical evolution 
was confirmed by the normality of the blood tests at the subsequent postoperative return visits (60, 180 and 356 days after 
the surgery). A year after the intervention, imaging exams were repeated and showed normal direction and velocity of the 
portal flow for the entire extra- and intrahepatic portal extension, liver growth with dimensions compatible with the species, 
and no blood flow in the anomalous vessel, as well as the presence of a radiopaque structure in the left epigastric region. 
Discussion: Regarding the choice of anesthetic protocols for these patients, attention had to be paid to the choice of drugs 
since the liver was already compromised and most drugs are metabolized in the liver. When it comes to the surgical pro-
cedure, the most common surgical complication would be portal hypertension, which occurs when total ligation of the 
anomalous vessel is performed. Although the surgical treatment is extremely challenging, the obstruction of abnormal 
blood flow of an anomalous vessel achieved by surgical placement of an ameroid ring was able to correct the hemody-
namic changes presented by the patient, and to reverse the hepatic insufficiency and the increase in the size of the liver.
Keywords: dog, canine, surgery, hepatic, insufficiency.
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INTRODUCTION
The portosystemic shunt is the most common 
hepatic circulatory abnormality in dogs, characterized 
by an abnormal deviation of the hepatic blood flow, 
that causes the blood that should be drained by the 
liver through the portal vein to be diverted to another 
systemic vein, due to the presence of the anomalous 
vessel. This deviation results in reduced hepatic blood 
flow and subsequent organ dysfunction [4,7], as well 
as the accumulation of many toxins in the circulation, 
such as ammonia and short-chain fatty acids. The shunt 
can be classified as intra or extrahepatic. 
The definitive diagnosis for this disease should 
be a summation, of the medical history, physical 
examination, complementary examinations such as 
ultrasonography (US), per-rectal portal scintigraphy, 
tomography, and/or exploratory laparotomy. The US 
test is a non-invasive method that is able to detect the 
blood flow deviation. However, a normal examination 
does not rule out the occurrence of a shunt [13]. 
The aim of the treatment for PDS is to cause 
the blood to flow back through the liver. The defi-
nitive treatment is surgical, correcting the vascular 
abnormality by means of ligation or implantation of a 
metal ring [5,7,8,10].
The objective of this article is to report the case 
of a patient with an extrahepatic portosystemic shunt, 
who underwent surgical treatment for correction of ab-
normal blood flow by obstructing the anomalous vessel 
with an ameroid constrictor. It presents the anesthetic 
and transurgical approaches and the postoperative 
follow-up for the period of one year, and demonstrates 
the evolution of the patient and the reestablishment of 
normality of the clinical signs during this period.  
CASE
We report the case of a female canine, Shih 
Tzu, 1 year and 8 months of age and weighing 3.9 
kg, with a history of daily vomiting and with smaller 
bodily structure and size than the other animals from 
the same litter. The animal was attended at the Vet-
erinary Hospital, previously diagnosed at age 1 month 
with a portosystemic shunt by means of complemen-
tary biochemistry, ultrasonography, and computed 
tomography examinations.  
The biochemical test showed all liver enzymes 
to be elevated, as shown in Table 1 (Time 1). The 
ultrasonography examination showed the liver with 
defined contours, regular margins, and reduced size, 
and both kidneys with increased echogenicity of the 
cortex and pelvis and the presence of calculi in the 
bladder. In the vascular ultrasonography, a diminished 
diameter of the portohepatic segment of the portal vein 
with hepatofugal flow was observed, and a tortuous 
calibrous vessel (0.62 cm) with apparent origin in the 
splenic vein and insertion in the azygos vein, charac-
terizing an extrahepatic portosystemic deviation and 
suggesting a splenic-azygos shunt.
Based on the above-mentioned findings, com-
puted tomography was performed and identified the 
anomalous vessel that originated in the left gastric vein 
and was inserted into the azygos vein in the portohe-
patic region. The examination revealed the vena cava 
with a diameter of 0.80 cm and the portal vein with a 
diameter of 0.41 cm.  
At the Veterinary Hospital, on the day of the 
first medical consultation, new blood tests were per-
formed, as shown in Table 1 (Time 2). 
On the day of the surgery, 30 days following 
the first visit, a new evaluation was made. A physical 
examination showed the animal to be normohydrated, 
with normocolored mucosa, capillary refill time (CRT) 
equal to 2 seconds and a strong pulse. Blood tests, as 
seen in Table 1 (Time 3) and arterial gasometry (i-
STAT CARTRIDGE EG7+®)1 showed a pH of 7.29, 
partial carbon dioxide pressure (PaCO2) of 38.1 mmHg, 
bicarbonate (HCO3-) of 18.7 mmol/L, oxygen satura-
tion (SpO2) at 81%, sodium (Na+) of 149 mmol/L, and 
potassium (K-) of 3.7 mmol/L. The patient’s cephalic 
vein was catheterized with a 22G catheter, simple 
Ringer’s solution2 fluid therapy was started at a veloc-
ity of 10 mL/kg/h, and an extensive trichotomy of the 
abdominal region was performed.  
As preanesthetic medication, an infusion of re-
mifentanil3 (Remifentanil Hydrochloride 2 mg - 0.3 µg/
kg/min) was administered. After 15 min of the infusion, 
anesthesia was induced with propofol3 (Propovan® - 
4 mg/kg) and the patient was intubated. Anesthetic 
maintenance was performed with isoflurane dissolved 
in 100% medicinal oxygen in a Baraka open circuit, 
without reinhalation. Also, for transurgical analgesic 
control, the remifentanil3 (Remifentanil Hydrochloride 
2 mg - infusion 0.3-0.5 µg/kg/min) was maintained 
until the end of the procedure. Subsequently, the right 
dorsal pedis artery was catheterized in order to measure 
arterial pressure invasively by means of a multipara-
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metric monitor. The patient was monitored using pulse 
oximetry, electrocardiography, and capnography. 
A median pre-retro-umbilical celiotomy of 
approximately 10 cm was performed, allowing the 
exploration of the organs of the abdominal cavity. 
The portal vein and vena cava were identified, and 
their diameters found to be compatible with the des-
cription from the vascular ultrasonography. A tortuous 
and calibrous vessel was identified originating at the 
junction of two splenic veins (Figure 1) and a gastric 
vein that penetrated the diaphragm and connected to 
the azygos vein in the thorax before flowing into the 
vena cava. In response to this finding, the diaphragm 
was sectioned, and the negative intra-thoracic pressure 
was lost, making it necessary to subsequently restore 
pressure and suture the muscle.  
The anomalous vessel had an approximate dia-
meter of 0.6 cm and a small dissection was performed 
around the vessel close to its origin for the placement 
of the ameroid constrictor4. A suture was performed 
around the constrictor to prevent its displacement 
along the vessel. The celiotomy was sutured at three 
levels: the muscle wall sutured with absorbable syn-
thetic thread (Polyglactin 910)5 and Sultan stitches; the 
subcutaneous tissue with absorbable synthetic thread 
(Polyglactin 910)5 and simple continuous stitches 
and skin with non-absorbable synthetic thread (Black 
monofilament nylon needled yarn)6 and Wolff-type 
stitches. No surgical complication was encountered 
during the procedure.
The procedure lasted 150 min. From the moni-
toring of the anesthesia, it was observed that the animal 
had SpO2 between 97 and 100%, with O2 flow at 10 
mL/kg/minute. The end-tidal carbon dioxide
 
(ETCO2) 
was maintained between 25 and 60 mmH20 throughout 
the anesthesia. 
The heart rate was maintained at between 85 
and 180 beats per minute (bpm). The animal’s mean 
arterial pressure was normal (MAP > 60 mmHg) 
for the first 90 min and then began to decline (MBP 
55 mmHg). As soon as hypotension was detected, a 
continuous dopamine7 (Dopamine Hydrochloride 5 
mg/mL - infusion 10-15 µg/kg/min) was initiated and 
maintained up until 110 min of anesthesia. 
The dog demonstrated a great deal of ab-
dominal pain and vocalization when coming out of 
anesthesia and it was decided to keep the patient on a 
remifentanil3 (Remifentanil Hydrochloride 2 mg - infu-
sion 0.3 µg/kg/min for 12 h). At the end of the infusion, 
the dog appeared to be well, without pain, and analgesia 
continued to be administered with morphine. 
During the hospitalization period (eight days), 
glycaemia, blood pressure, temperature, heart rate, 
respiratory rate, and response to painful stimuli from 
abdominal palpation were monitored daily. Metroni-
dazole3 (Metronizadole 5 mg/mL - 15.0 mg/kg, twice 
a day, 7 days), ceftriaxone8 (Amplospec® 1 g - 30.0 
mg/kg, twice a day, 8 days), meloxicam9  (Elo-xicam® 
0,2% - 0.1 mg/kg, once a day, 4 days), and morphine10 
(Morphine Sulfate 10 mg/mL -  0.5 mg/kg, every 4 h, 
3 days) were administered. 
On the second day, there was a drop-in glycae-
mia (mean value of 60 mg/dL) and glucose solution 
fluid therapy was instituted. However, the glycaemia 
remained low and 3.0 mL of an industrialized prod-
uct rich in glucose was administered orally, restoring 
the physiological values for the species, which were 
maintained throughout the day. The glucose solution 
was maintained until the 5th day of hospitalization.  
On the second day, a decrease in systolic 
arterial pressure (SAP = 100 mmHg, decreased SAP 
= 80 mmHg) was observed and a colloid fluid bolus3 
[Voluven® 6% 10.0 mL/kg was administered, repeated 
8 h later (5.0 mL/kg)], reestablishing the pressure to 
normal values. The hemogram was repeated, showing 
leukocytosis, Table 1 (Time 4). On the fourth day, the 
morphine10 (Morfine Sulfate 10 mg/mL) was replaced 
by tramadol chlorhydrate11 (4.0 mg/kg, three times a 
day, 4 days). 
Ten days following surgery the blood tests were 
repeated (Table 1, Time 5) and the clinical evaluation 
showed the patient to be active, without pain, and fully 
recovered. The radiographic and abdominal vascular 
ultrasound examinations were repeated and showed the 
presence of the metal ring in the left epigastric region 
(Figure 2), favorable evolution of the characteristics of 
portal vascular flow, with normal hepatoportal direc-
tion and velocity throughout the extra- and intrahepatic 
extension, a slight enlargement of the liver, and reduced 
blood flow in the anomalous vessel. 
The patient was discharged at ten days follo-
wing surgery with a prescription of adenosylmethioni-
ne (SAME 150.0 mg)12, 1 capsule, orally, once a day; 
silymarin12 (39.0 mg, 1 capsule, orally, three times 
a day); and a diet based on commercial low-protein 
kibble and cottage cheese. 
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At the 20-day postoperative follow-up visit, the 
dog was clinically well, the blood test results within 
normal ranges for the species, but the owners reported 
that it was reluctant to eat the prescribed food, so an 
adjusted diet of rice, cooked potato, cooked squash, 
and meat was suggested.
At the subsequent 60-, 180-, and 365-day 
postoperative return visits, the clinical evolution of the 
patient was confirmed by the normality of the blood 
tests and weight gain (4.2 kg) and no episodes of apa-
thy, anorexia, or vomiting. The imaging examinations 
were repeated a year after the procedure and revealed 
portal flow exhibiting normal direction and velocity 
for the entire extra- and intrahepatic portal extension, 
an increase in liver measurements with dimensions 
compatible with the species, and the absence of blood 
flow in the anomalous vessel, as well as the presence 
of a radiopaque structure in the left epigastric region. 
DISCUSSION
Congenital portosystemic deviations (PSD) are 
usually diagnosed in animals under one year of age 
with symptoms related to the central nervous system 
and the gastrointestinal and urinary tracts, but age 
group alone does not serve to differentiate acquired 
from congenital shunts [13]. Hemodynamic changes 
were observed in the case described, in which the pa-
tient was older than one year of age and presented both 
urinary tract and gastrointestinal tract signs. 
Generally, affected animals present small body 
structure, an inability to grow, or weight loss [4]. This 
liver dysfunction also may present non-specific signs 
such as anorexia, polyphagia, vomiting, intermittent 
diarrhea, and hepatic encephalopathy [5,9]. This ani-
mal was the smallest of the litter and also presented a 
history of recurrent vomiting.
Taking breed epidemiology into account, the 
breeds most affected by this condition are miniature 
Schnauzers, Yorkshire Terriers, Poodles, Maltese, Shih 
Tzus, and Dachshunds [4], as in the reported case, in 
which the patient was a Shih Tzu and with a history 
of consanguinity.
In a portosystemic shunt, decreased liver size, 
as exhibited in the initial imaging exams, is a direct 
consequence of reduced blood flow, decreasing the 
ability of the liver to metabolize the intestinal toxins 
that accumulate in the blood [3,13]. The kidneys and 
bladder should also be examined, in the search for 
Table 1. Table showing values from hemogram, leukogram, and serum biochemistry performed at different times during the monitoring 
of a patient submitted to surgical correction of an extrahepatic portosystemic shunt using an ameroid ring.  
Type of 
exam
Variables
Values observed
Time 1 
(Before treatment 
at the VH-UVV)
Time 2
(First treatment 
at the VH-UVV)
Time 3
(Day of surgery - 30 
days after Time 2)
Time 4
(2 days following 
surgery)
Time 5
(10 days after 
surgery)
Hemogram/
Leukogram
Erythrocytes 9.75 million/µL 7.65 million/µL 8.5 million/µL 7.62 million/µL 5.70 million/µL
Hematocrit 46.0% 39.3% 43.7% 39.3% 32.4%
MCV 47.2 fl 51.5fl 51.1fl 51.6 fl 57.0 fl
MCHC 32.6 % 34.6% 32.2% 33.0% 32.4%
Protein 7.2 g/dL 5.6 g/dL 6.0 g/dL 4.0 g/dL 6.0 g/dL
Leukocytes 8.800/µL 18.800/µL 19.000/µL 26.900/µL 23.600/µL
Bands 0% 1% 0% 2% 0%
Segmented 49% 73% 74% 80% 77%
Lymphocytes 47% 22% 15% 14% 18%
Platelets 132 mil/µL 301mil/µL 371 mil/µL 269 mil/µL 376 mil/µL
Biochemistry
ALT 181.2 UI/L 131 UI/L 96.0 UI/L - 158.9 UI/L
Creatinine 0.52 mg/dL 0.6 mg/dL 0.6 mg/dL - 0.7 mg/dL
Urea 17.8 mg/dL 11.6 mg/dL 21.7 mg/dL - 19.2  mg/dL
AST 67.6 UI/L - 66.3 UI/L - -
AP 234.0 UI/L 113 UI/L 110.3 UI/L - 209.5 UI/L
GGT 18.9 U/L - 8.8 UI/L - -
Total protein 5.93 g/dL 5.1 g/dL 6.0 g/dL - -
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Figure 1. Anatomical aspect of the anomalous vessel of approximately 0.6 cm in diameter, viewed during the surgery (arrow), coming from two splenic 
veins and one gastric vein (A). Positioning of the metal ameroid constrictor in the proximal portion of the anomalous vessel (B).
Figure 2. Radiographic exam performed 10 days following surgery of a patient treated surgically to obstruct the anomalous vessel using an ameroid 
constrictor. A- Lateral projection of the abdominal region showing a radiopaque structure in the form of a ring, located below the twelfth thoracic ver-
tebra proximal to the stomach. B- Ventro-dorsal projection of the abdominal region showing a radiopaque structure in the form of a ring located in the 
left epigastrium next to the twelfth thoracic vertebra (D = right).
urate urolithiasis, as in the reported case where bladder 
calculus was found. In most cases, the bladder calculus 
found were due to the accumulation of ammonia in the 
blood, which is filtered by the kidneys, resulting in the 
calculi observed [3,7]. The liver enzymes alanine ami-
notransferase (ALT) and aspartate aminotransferase 
(AST) and alkaline phosphatase (FA) may be normal 
to slightly elevated, as in the case described [4].
Dogs with congenital portosystemic shunts 
tend to have hypoglycemia caused by glycogen insu-
fficiency due to the inadequate capacity of the liver to 
store glucose, to abnormal insulin metabolism, and to 
surgery and anesthesia-induced stress [4,7]. Associated 
with these conditions, the patient also presented hypo-
glycemic peaks during hospitalization due to low food 
intake, despite the dietary prescription. 
Extrahepatic shunts can originate from the 
portal vein, left gastric vein, or splenic vein, directing 
the flow to the caudal vena cava, azygos vein, or other 
systemic veins without passing through the liver [7]. 
In this case report, it was an extrahepatic shunt that 
originated from two splenic veins and one gastric vein 
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in the direction of the diaphragm, and met up with the 
azygos vein in the thoracic region.
Regarding the choice of anesthetic protocols 
for these patients, attention must be paid to the choice 
of drugs since the liver is already compromised and 
most drugs are metabolized in the liver [6,11]. The 
choice of remifentanil, a µ-receptor agonist opioid 
of ultra-short duration (approximately 5 min), as the 
preanesthetic medication and transoperative analgesic, 
was due to high solubility and potent analgesia. It was 
used in continuous infusion, mainly due to its pharma-
cokinetics [1,11]. Its composition includes a methyl 
ester side chain that allows metabolism by non-specific 
blood and tissue esterases (carboxylesterase), without 
hepatic metabolism, as with fentanil. Its duration is 
very short, a result of extensive extrahepatic metabo-
lism, unlike other opioids that depend on redistribu-
tion to the tissues to terminate the effect and hepatic 
metabolism for excretion. Remifentanil is a powerful 
respiratory depressant and if used during anesthesia, 
mechanical ventilation may be required [1]. Opioids 
markedly lower the concentration of volatile anesthetic 
agents, reducing the collateral effects caused by them 
[2,11]. Recovery from this drug is rapid, even after 
prolonged infusion, since its plasmatic concentration 
is reduced by 50% after 3 to 10 min, regardless of the 
infusion time [11]. However, its rapid metabolism can 
result in a decline in analgesia during recovery [2,11].
Propofol, an intravenous general anesthetic 
that is redistributed and metabolized extremely rapi-
dly, was used for induction. Propofol causes a loss of 
consciousness within 20 to 40 s when administered 
via IV and its clearance exceeds hepatic blood flow, 
indicating that other locations, in addition to the liver, 
participate in its excretion [2,11].
As regards the surgical procedure, the most 
common surgical complication is portal hypertension, 
which occurs when total ligation of the anomalous 
vessel is performed [5,9]. This occurs because the 
hepatic vessels are not yet able to withstand the large 
blood flow that, suddenly, begins to pass through the 
liver. In order to prevent this hemodynamic complica-
tion, it is important that the occlusion of the vessel be 
gradual, no matter which technique is chosen. For this 
reason, cellophane and suture threads were not used 
during the corrective procedure to prevent the radical 
obstruction of the vessel [5,8,10], opting instead for 
the metal constrictor.
It is known that the ameroid ring, chosen as 
the biomaterial to accomplish the obstruction of the 
anomalous flow during the procedure, can absorb 
liquids slowly, causing the internal part of the ring to 
increase in volume, reducing the central diameter, and 
gradually constricting the vessel due to the expansion 
of the ameroid substance. Occlusion occurs as fibrosis 
develops around the vessel and, although several fac-
tors can alter the closing velocity, the fastest expansion 
normally occurs between the 3rd and the 14th day after 
implantation [8,10]. Corroborating the statements of 
the authors, a significant decrease in the blood flow of 
the anomalous vessel and favorable evolution of the 
characteristics of the portal vascular flow were obser-
ved in the vascular ultrasound examination performed 
ten days after surgery. 
The biggest challenge during the surgical 
procedure was identifying the anomalous vessel, 
even with prior anatomical knowledge and the help 
of transsurgical ultrasonography, since anatomical 
references, such as the portal vein, the vena cava, and 
the abdominal organs, such as the liver, were altered. 
In addition, the anatomical surgical aspect is not always 
compatible with the description in the reports, which 
creates insecurity at the moment of ligation. Difficulty 
identifying the anomalous vessels was not reported by 
any author during the biographical research conducted, 
however, even with a trained surgical team and with 
prior anatomical knowledge, it is inferred that said 
difficulty is common to all the procedures, though 
not reported.
Parker et al. [12] accompanied 64 dogs follo-
wing surgery to correct portosystemic shunts, both 
intra- and extrahepatic. They reported average survival 
of 51 months for patients with extrahepatic and 30 
months for those with intrahepatic shunts. However, 
the morbidity and mortality rates observed were high 
(approximately 50%), with 6% dying in the immediate 
postoperative period, 17% dying by the tenth day, and 
25% by the eighth month of follow-up. The evolution 
of the patient reported was satisfactory during the 12 
months of follow-up, with a notable gain in body weight, 
normal blood and biochemistry exams, and visualiza-
tion of the normal direction and velocity of the portal 
vein flow and absence of blood flow in the anomalous 
vessel. Although the surgical treatment is extremely 
challenging, obstruction of abnormal blood flow of an 
anomalous vessel achieved by surgical placement of 
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an ameroid ring was able to correct the hemodynamic 
changes presented by the patient, and to reverse the 
hepatic insufficiency and the increase in the size of the 
liver. During patient follow-up, we confirmed weight 
gain, the absence of episodes of vomiting, and normal 
laboratory blood test values, all of which are variables 
that reinforce the success of the treatment performed. 
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